The Proteomics Shared Resource offers state-of-the-art, user-friendly mass spectrometry-based resources to support Cancer Institute members. In addition to providing facilities and services, the Shared Resource enables education, methods development and new applications, designed to meet the rapidly evolving needs of cancer researchers. The Shared Resource operates under the direction of Dr. Allis Chien, with oversight by an interdisciplinary faculty advisory committee. It currently occupies 2200 sq ft of space in a convenient, accessible central campus location, and employs six staff scientists in addition to Dr. Chien. The Shared Resource houses 14 mass spectrometers and associated instrumentation; these include single quadrupole, ion trap, triple quadrupole, Q-TOF and Orbitrap mass spectrometers, with appropriate chromatography front ends. In-house proteomics data processing capabilities include Proteome Discoverer, Mascot, Scaffold, Byonic, Skyline, PEAKS and MaxQuant. Annual operating costs are $1.2M. The facility operates on a cost-recovery basis, with ongoing expenses recovered primarily through user fees. Since 2009, over 80 SCI members have used the Shared Resource. Future goals include the implementation of newly installed MS instrumentation, expansion of protein network analysis and quantitative proteomics services, and enhancement of bioinformatics capabilities. Services provided include: peptide and protein identification, characterization of post-translational modifications, protein quantitation, biomarker verification and metabolic studies. In addition, the Proteomics Shared Resource seeks to educate the Stanford research community on how their research can be enhanced and improved by MS methods. With the availability of quality on campus mass spectrometry support, researchers become more involved with experimental design, data analysis, and results interpretation, developing a real understanding of the MS results. Close proximity between the facility and campus research laboratories promotes interactions between researchers and the Proteomics team. These interactions are mutually beneficial and can lead to new paths of research investigation. Stanford researchers have come to expect and value this type of support from the Shared Resource; Cancer Institute members use this Shared Resource frequently, with half of all usage in FY2014 from members.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA124435-10
Application #
9308880
Study Section
Special Emphasis Panel (ZCA1-RTRB-0)
Project Start
Project End
Budget Start
2017-06-01
Budget End
2018-05-31
Support Year
10
Fiscal Year
2017
Total Cost
$58,074
Indirect Cost
$21,322
Name
Stanford University
Department
Type
Domestic Higher Education
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Champion, Magali; Brennan, Kevin; Croonenborghs, Tom et al. (2018) Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response. EBioMedicine 27:156-166
Zhou, Mu; Leung, Ann; Echegaray, Sebastian et al. (2018) Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications. Radiology 286:307-315
Pollom, Erqi L; Fujimoto, Dylann K; Han, Summer S et al. (2018) Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. J Radiat Res 59:i11-i18
Nørgaard, Caroline Holm; Jakobsen, Lasse Hjort; Gentles, Andrew J et al. (2018) Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study. PLoS One 13:e0193249
Im, Hogune; Rao, Varsha; Sridhar, Kunju et al. (2018) Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells. Leuk Lymphoma 59:2952-2962
Huang, Min; Zhu, Li; Garcia, Jacqueline S et al. (2018) Brd4 regulates the expression of essential autophagy genes and Keap1 in AML cells. Oncotarget 9:11665-11676
Chiou, Shin-Heng; Dorsch, Madeleine; Kusch, Eva et al. (2018) Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Sci Rep 8:14008
Breslow, David K; Hoogendoorn, Sascha; Kopp, Adam R et al. (2018) A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies. Nat Genet 50:460-471
Chu, Lisa W; Till, Cathee; Yang, Baiyu et al. (2018) Circadian genes and risk of prostate cancer in the prostate cancer prevention trial. Mol Carcinog 57:462-466
Patel, Manali I; Sundaram, Vandana; Desai, Manisha et al. (2018) Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol 4:1359-1366

Showing the most recent 10 out of 322 publications